Pharmaceuticals
By 2050, drug-resistant infections could cause global economic damage worse than 2008 financial crisis
24 Sep 2016
Drug-resistant infections have the potential to cause a level of economic damage similar to — and likely worse than — that caused by the 2008 financial crisis, according to a new report by the World Bank Group
Allergan to buy Tobira Therapeutics for $1.7 bn
20 Sep 2016
Zydus Cadila to partner Takeda Pharmaceutical to develop and commercialise vaccine against chikungunya
20 Sep 2016
US drugmaker Depomed explores sale
16 Sep 2016
Make drugs affordable, delink prices from R&D costs: UN panel
16 Sep 2016
The report calls for human rights to be placed over intellectual property laws and all countries must freely be able to use flexibilities granted under TRIPS to access affordable medicines
.webp)
